Evaluation of Tofacitinib in Early Diffuse Cutaneous Systemic Sclerosis (dcSSc)
Clinical trial NCT03274076 · COMPLETED
Trial details
- NCT number
- NCT03274076
- Sponsor
- University of Michigan
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-25
- Primary completion
- 2019-04-08
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.